Speech-Language Pathologists in Billings, MT Accepting Medicare

116 Speech-Language Pathologists found. Showing 61 - 80

Haley Stukel, M.S. CFY-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1610 Poly Dr, Billings, MT 59102 Phone: 406-259-1680    Fax: 406-259-1777

Jonalyn Brown, ST Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2675 Central Ave, Billings, MT 59102 Phone: 406-238-2500

Billings Clinic Speech Therapy Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 801 N 29th St, Billings, MT 59101 Phone: 406-238-2500

Elizabeth Briskey Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1597 Avenue D, Billings, MT 59102 Phone: 406-690-6996

Speech And Feeding Pathways Llc Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 100 24th St W Ste 1-1258, Billings, MT 59102 Phone: 563-203-1122

Mrs. Stephanie Wightman, M.A., CCC-SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 1655 Shiloh Rd Ste D, Billings, MT 59106 Phone: 406-629-1175

Morgan Malany, M.S., SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 801 N 29th St, Billings, MT 59101 Phone: 406-238-2500

Lisa D Kness, M.S., C.C.C., S-LP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 985 Peachtree Rd, Billings, MT 59102 Phone: 406-534-4515    Fax: 406-534-4514

Melissa D Peterson, MS, SP-LIC Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 708 Broadwater Ave, Billings, MT 59101 Phone: 406-259-1680    Fax: 406-259-1777

Britta Dalbey Speech-Language Pathologist Medicare: Accepting Medicare Assignments Practice Location: 3155 Avenue C, Billings, MT 59102 Phone: 406-545-8119    Fax: 406-545-8119

Mrs. Kathleen Delapp Cohn, SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 1302 24th St W # 132, Billings, MT 59102 Phone: 888-241-4332    Fax: 888-241-4332

Mrs. Rebekah J Mckenzie, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6068 Ironwood Dr, Billings, MT 59106 Phone: 406-530-7188    Fax: 844-415-2186

Katherine Freeman, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2351 Solomon Ave, Billings, MT 59102 Phone: 727-470-1366

Mrs. Sherri A Maxwell, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 50 27th St W, Suite B, Billings, MT 59102 Phone: 406-651-9099    Fax: 406-651-4332

Tori Hepp, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3940 Rimrock Rd, Billings, MT 59102 Phone: 406-655-5600

Kay Pusey, MA, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2900 12th Ave N, Ste 300e, Billings, MT 59101 Phone: 406-238-6400

Mary Michelle Collins, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1415 Yellowstone River Rd, Billings, MT 59105 Phone: 406-245-9330

Katie Anne Peretti, ST Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2800 10th Ave N, Billings, MT 59101 Phone: 406-238-2500

Cedar Lane Speech Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1928 St Andrews Dr, Billings, MT 59105 Phone: 406-813-2181    Fax: 406-630-0872

Michael Krencicki Jr., MS, CF-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2900 12th Ave N Ste 10w, Billings, MT 59101 Phone: 406-238-6400

News Archive

AstraZeneca selects Regulus' RG-125 as clinical candidate for treatment of NASH

Regulus Therapeutics Inc., a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs, announced today the selection of RG-125 (AZD4076), a GalNAc-conjugated anti-miR targeting microRNA-103/107 ("miR-103/107") for the treatment of Non Alcoholic Steatohepatitis ("NASH) in patients with type 2 diabetes/pre-diabetes, as a clinical candidate by AstraZeneca under the companies' strategic alliance to discover, develop and commercialize microRNA therapeutics.

Experts examine COBRA subsidy program following its expiration

Business Insurance: "The once politically popular program that provides COBRA premium subsidies for involuntarily terminated employees is winding down as broad congressional support has nearly vanished, experts say. Embedded in a 2009 economic stimulus measure and renewed several times since then, the program in which the federal government pays 65% of the COBRA premium has enabled millions of employees who lost their jobs and their dependents to keep group coverage by making it more affordable."

Study provides new way to develop unconventional anticancer strategies

There is considerable interest in a new class of anticancer molecules that is currently still under investigation termed the cationic antimicrobial peptides (AMPs).

Optogenetics helps to restore optimal movement in people with physical disabilities

Researchers at Stanford University were able to use light to induce normal patterns of muscle contraction, in a study involving bioengineered mice whose nerve-cell surfaces are coated with special light-sensitive proteins.

Read more Medical News

› Verified 4 days ago

• 1
• 2
• 3
• 4(current)
• 5
• 6